This study was designed to investigate the pathogenesis of gynaecomastia by measuring phosphatase and tensin homologue (PTEN), O 6 -methylguanine-DNA methyltransferase (MGMT) and DNAdependent protein kinase catalytic subunit (DNA-PKcs) protein in breast tissue specimens from 68 patients with gynaecomastia and 24 normal male controls using immunohistochemical staining. The gynaecomastia cases were divided into three different histological types: florid, intermediate and fibrous. The PTEN, MGMT and DNA-PKcs proteins were detected in both gynaecomastia and normal breast tissue, but the levels of immunohistochemical staining of each protein were significantly lower in gynaecomastia breast tissue than in normal breast tissue. There were also significant differences in the levels of immunohistochemical staining for the three proteins according to gynaecomastia histological type. These results suggest that abnormally low levels of PTEN, MGMT and DNA-PKcs protein in gynaecomastia breast tissue may play a role in the development of gynaecomastia. Further research is required to elucidate fully their individual roles in the pathophysiology of gynaecomastia.
Introduction
Gynaecomastia is a benign enlargement of the male breast resulting from a proliferation of the glandular component of the breast, 1 but its pathogenesis is not clearly understood. There is some evidence that gynaecomastia is a risk factor for male breast cancer (MBC) or is related to the development of MBC. 2, 3 It is not clear whether the excess masculine mastoplasia L Zhu, Z Liu, J Yang et al.
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observed in gynaecomastia has similar oncobiological characteristics as MBC, or if the DNA of the breast cells has been damaged and, if so, what repair mechanisms might have taken place.
The phosphatase and tensin homologue deleted on chromosome 10 (PTEN) is a dualspecificity phosphatase with both protein phosphatase and lipid phosphatase activity. 4 PTEN plays an important role in apoptosis, cell cycle arrest and cell migration, and it has been found to be mutated in many cancers such as heritable and sporadic breast cancer. 5 As an important DNA repair enzyme, O 6 -methylguanine-DNA methyltransferase (MGMT) plays a role during the repair of DNA damage. 6 The methylation status of MGMT is associated with the incidence, clinical features and response to chemotherapeutic agents of tumours. DNAdependent protein kinase (DNA-PK) is an enzyme that plays an essential role in the repair of non-homologous DNA doublestrand breaks. 7 The DNA-PK catalytic subunit (DNA-PKcs) is a very important cellular factor that plays a key role in biological processes such as DNA repair and gene recombination. 8, 9 Despite the importance of these three proteins, PTEN, MGMT and DNA-PKcs, there have been no reports about their potential role in the development of gynaecomastia. The present study used immunohistochemistry to detect these proteins in the breast tissue of patients with gynaecomastia compared with normal male mammary glands with the aim of investigating the potential role of these three proteins in the development of gynaecomastia.
Patients and methods

PATIENTS
In this observational study, breast tissue samples were collected from patients with gynaecomastia from the Second Hospital of Shandong University, Jinan, China, and Qilu Hospital, Shandong University, Jinan, China, between July 2003 and August 2005. All specimens were obtained during the mastectomy procedures that were used to treat patients with gynaecomastia, which were undertaken for cosmetic reasons. Control specimens without breast disease were retrieved from the autopsies of male corpses from the Anatomy Department of Shandong University Medical School. The study protocol was approved by the Medical Ethics Committee of Shandong University, Jinan, China. All patients were required to give written informed consent prior to participation in the study.
DETERMINATION OF HISTOLOGICAL TYPE
Histology of the gynaecomastia samples was examined by preparation of 4-µm thick, routinely-processed paraffin sections of the breast tissue and staining using standard haematoxylin and eosin staining. The gynaecomastia samples were divided into three groups: florid, intermediate and fibrous types according to the histological classification system of Bannayan and Hajdu. 10
IMMUNOHISTOCHEMISTRY
Immunohistochemistry was performed on 4µm thick, routinely-processed paraffin sections of breast tissue. The primary monoclonal antibodies used were directed against PTEN, MGMT and DNA-PKcs: PTEN was detected with a rabbit monoclonal anti-PTEN antibody (clone 138G6, 1:100 dilution; Cell Signaling Technology ® , Danvers, MA, USA); MGMT was detected with a mouse monoclonal anti-MGMT antibody (clone MT 23.2, 1:100 dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA); and L Zhu, Z Liu, J Yang et al.
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DNA-PKcs was detected with a mouse monoclonal anti-DNA-PKcs antibody (clone 18-2, dilution 1:200; Santa Cruz Biotechnology). Sections were dewaxed and endogenous peroxidase was blocked by immersing the slides in a 3% solution of hydrogen peroxide in methanol for 10 min. This was followed by an antigen retrieval step for all three antibodies, in which the slides were immersed in 10 mM citrate buffer solution (pH 6.0) and placed in a microwave oven for 15 min. After a tap water bath, the sections were covered with non-immune horse serum for 30 min. After removing the serum, the sections were covered with the primary antibodies and incubated overnight at 4°C in a humidity chamber. Then, the sections were rinsed with 50 mM Trisbuffered saline (TBS) before being incubated with the secondary biotinylated goatantimouse or goat-antirabbit IgG antibodies (R&D Systems Inc, Minneapolis, MN, USA) for 40 min at 37°C in a humidity chamber. After rinsing with TBS, the streptavidinperoxidase complex reagent (StrepABComplex/HRP Duet; Dako, Glostrup, Denmark) was applied for 30 min at 37°C. After washing, 3,3′-diaminobenzidine (DAB) was applied for 5 min under a light microscope. Sections were then immersed in running tap water, counterstained with haematoxylin for 1 min, followed by a tap water bath. The sections underwent immersion in a series of alcohol baths of increasing concentrations and then xylene, before being overlaid with cover slips. Negative controls, in which the primary antibody was omitted, and positive controls of PTEN, MGMT and DNA-PKcs were included in each batch of immunohistochemical staining.
ASSESSMENT OF IMMUNOSTAINING
Immunostaining was scored separately by two pathologists for the percentage of immunopositive cells. For each section, 10 high power fields (magnification ×400) were selected at random and examined under a light microscope. A total of 1000 mammary ductal epithelial cells were read per slide, i.e. 100 cells/high power field. The labelling index (LI) was calculated as follows and expressed as a percentage: LI = (labelled cells/total cells) × 100. The LI score for percentage of positive cells was defined as: 0, LI < 5%; 1, 5% ≤ LI < 25%; 2, 25% ≤ LI < 75%; and 3, LI ≥ 75%.
STATISTICAL ANALYSIS
The data were analysed by χ 2 -test and Ridit analysis for statistical significance using SPSS ® version 11.5 (SPSS Inc., Chicago, IL, USA) for Windows ® . A P-value < 0.05 was considered to be statistically significant.
Results
Sixty-eight breast tissue samples from patients with gynaecomastia were collected. The mean age of the patients with gynaecomastia was 30.2 years (range 18 -68 years). The mean course of the disease was 5.3 years (range 4 months to 9.7 years). Of these 68 patients, 53 presented with bilateral and 15 with unilateral gynaecomastia (left 7; right 8). Thirty-three cases had an identified cause of the disease, such as liver disease, hyperthyreosis, testis disease or drugs, and 35 had no definite cause and presented with idiopathic gynaecomastia. No carcinoma was observed in any of the gynaecomastia cases examined. The mean age of the 24 deceased patients that provided the control breast tissue samples was 39.8 years (range 23 -56 years).
The gynaecomastia samples were divided into three groups according to the histological classification of Bannayan and Hajdu: 10 The characterristic histology of these three types is presented in Fig. 1 .
Immunohistochemistry demonstrated the presence of PTEN, MGMT and DNA-PKcs proteins in the mammary ductal epithelial cells of normal male breast tissue and breast samples from patients with gynaecomastia. In normal male breast tissue, PTEN was mainly located in the nucleus, with some localization in the cytoplasm of ductal epithelial cells (Fig. 2) . In contrast, PTEN was localized in the nucleus and the nucleolemma of ductal epithelial cells in the gynaecomastia samples (Fig. 2 ). Both MGMT ( Fig. 3 ) and DNA-PKcs (Fig. 4) proteins were localized in the nuclei of ductal epithelial cells of normal male breast tissue and gynaecomastia samples.
Significantly more of the gynaecomastia samples had lower levels of immunohistochemical staining for PTEN, MGMT and Table 1 ). This was indicative of downregulation of PTEN, MGMT and DNA-PKcs protein in gynaecomastia tissue compared with normal male breast tissue.
The LI score distribution for PTEN, MGMT and DNA-PKcs protein according to the three different histological types of gynaecomastia breast tissue was also statistically significantly different (P < 0.05 with the χ 2test and Ridit analysis; Table 2 ). Significantly more patients with the fibrous type had a higher LI score and more patients with the florid type had a lower LI score; the LI score for the percentage of positive cells: 0, LI < 5%; 1, 5% ≤ LI < 25%; 2, 25% ≤ LI< 75%; and 3, LI ≥ 75%. 
Discussion
The pathophysiological mechanisms involved in the development of gynaecomastia and the proliferation of breast tissue might include a number of key changes: (i) an abnormality in the levels of circulating sex hormones; (ii) a change in reactivity of the breast tissue in response to changes in sex hormone levels; (iii) abnormal sex hormone metabolism; and (iv) functional or organic changes in the endocrine axis controlled by the hypothalamus-appendix cerebri. 11, 12 The specific mechanism involved in the proliferation of the mammary gland that is observed in cases of gynaecomastia has not yet been identified. 13 -15 Results from the present study indicated that the expression of PTEN protein was decreased in gynaecomastia breast tissues compared with normal male breast tissue, a change similar to that seen in many cancers. For example, Wan et al. 16 reported that PTEN expression was significantly lower in breast cancers compared with benign breast tumours; both PTEN mRNA and protein expression rates were 100% in benign breast tumours, but only 51.4% and 47.1%, respectively, in breast cancers. Liu et al. 17 measured PTEN protein expression in 42 breast cancer tissue samples and 15 normal mammary glands, and found the expression rates were 35.7% and 80.0%, respectively; the difference between them was statistically significant. Although this finding does not confirm a direct relationship between gynaecomastia and MBC, it is an important prerequisite to exclude MBC in the diagnosis and management of gynaecomastia.
Most researchers consider that PTEN protein is mainly localized in the cytoplasm. Chung and Eng 5 have, however, shown that PTEN localizes in the nucleus and that this localization coincides with the G0/G1 phases of the cell cycle. They also observed that nuclear PTEN was required for cell cycle arrest but that cytoplasmic PTEN was required for apoptosis. 5 Their observations provide further evidence that reduced nuclear expression of PTEN could play a role in carcinogenesis. The present study also demonstrated that PTEN was mainly localized in the nucleus. Based on the conclusions of Chung and Eng, 5 it could be suggested that the subcellular localization of PTEN in mammary ductal epithelial cells might regulate its individual function. Furthermore, deregulation of cell cycle arrest might play an important role in ductal epithelial cell hyperplasia. The present study hints that PTEN-related cell cycle arrest could change in the development of gynaecomastia. It also showed that levels of PTEN protein expression were highest in the fibrous histological type and lowest in the florid type, with the intermediate type showing expression levels between the two. This suggests that variation in PTEN expression may be correlated with the degree of ductal epithelial cell proliferation. The specific mechanism by which this occurs requires further research.
The present study showed a downregulation of MGMT protein in gynaecomastia breast tissue compared with normal male breast tissue. It could be presumed from these findings that DNA damage had been caused by events occurring during the development of gynaecomastia which, in turn, might lead to reduced MGMT activity and an associated diminished DNA reparation capability, resulting in ductal epithelial cell
